X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (17) 17
humans (12) 12
female (9) 9
male (9) 9
adult (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
biochemistry & molecular biology (7) 7
fungi (7) 7
middle aged (7) 7
oncology (7) 7
plant sciences (7) 7
aged (6) 6
hematology (6) 6
treatment outcome (6) 6
aged, 80 and over (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
disease (5) 5
analysis (4) 4
ascomycota - enzymology (4) 4
ascomycota - genetics (4) 4
care and treatment (4) 4
chemotherapy (4) 4
genes (4) 4
plant roots - metabolism (4) 4
prednisone - administration & dosage (4) 4
truffles (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
cancer (3) 3
doxorubicin - administration & dosage (3) 3
ecology (3) 3
enzymes (3) 3
evolution (3) 3
fungal proteins - genetics (3) 3
fungal proteins - metabolism (3) 3
gene expression (3) 3
genomics (3) 3
hodgkin disease - drug therapy (3) 3
hodgkin disease - mortality (3) 3
identification (3) 3
life sciences (3) 3
molecular sequence data (3) 3
mycology (3) 3
non-hodgkins-lymphoma (3) 3
plant roots - microbiology (3) 3
plants - metabolism (3) 3
prednisone - adverse effects (3) 3
procarbazine - administration & dosage (3) 3
prognosis (3) 3
proteins (3) 3
symbiosis (3) 3
vinblastine - administration & dosage (3) 3
vincristine - administration & dosage (3) 3
age (2) 2
aggressive nhl (2) 2
agriculture (2) 2
amino acid sequence (2) 2
animals (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
ascomycota - chemistry (2) 2
ascomycota - growth & development (2) 2
ascomycota - physiology (2) 2
bleomycin - administration & dosage (2) 2
brassica-juncea (2) 2
chop chemotherapy (2) 2
combination chemotherapy (2) 2
corylus - microbiology (2) 2
cyclophosphamide - administration & dosage (2) 2
cyclophosphamide - adverse effects (2) 2
dacarbazine - administration & dosage (2) 2
degradation (2) 2
development (2) 2
doxorubicin - adverse effects (2) 2
efficacy (2) 2
epirubicin - administration & dosage (2) 2
europe (2) 2
expression (2) 2
forestry (2) 2
fruiting bodies, fungal - metabolism (2) 2
gene expression profiling (2) 2
genetic aspects (2) 2
genetic research (2) 2
genome (2) 2
growth (2) 2
health aspects (2) 2
hodgkin's lymphoma (2) 2
hybrid (2) 2
insights (2) 2
italy (2) 2
limited radiotherapy (2) 2
lomustine - administration & dosage (2) 2
lymphoma, non-hodgkin - drug therapy (2) 2
lymphoma, non-hodgkin - pathology (2) 2
lymphomas (2) 2
melanin (2) 2
mopp (2) 2
mycelium - enzymology (2) 2
mycorrhizae - genetics (2) 2
mycorrhizae - growth & development (2) 2
non-hodgkin's lymphoma (2) 2
non-hodgkin's lymphomas (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 04/2010, Volume 464, Issue 7291, pp. 1033 - 1038
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2011, Volume 29, Issue 32, pp. 4227 - 4233
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 10/2011, Volume 19, Issue 10, pp. 1505 - 1510
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2011, Volume 153, Issue 3, pp. 351 - 357
Journal Article
Hematology Reports, ISSN 2038-8322, 2011, Volume 3, Issue 3, pp. 10 - 13
Since anthracyclines were introduced in the treatment of non-Hodgkin's lymphoma in the late 1960s, they have been acknowledged as a cornerstone in the... 
Anthracycline | Non-hodgkin's lymphoma | Treatment
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 03/2012, Volume 53, Issue 3, pp. 406 - 410
Abstract Polymorphisms of the Glutathione-S Transferase (GST) family may influence the prognosis in lymphoma patients. We aimed to validate the impact of GSTT1... 
GSTT1 | polymorphism | GSTM1 | prognosis | Hodgkin's lymphoma | Prognosis | Polymorphism | SUSCEPTIBILITY | RISK | ACUTE MYELOID-LEUKEMIA | CANCER | CHEMOTHERAPY | GENOTYPES | THERAPY | ONCOLOGY | DISEASE | HEMATOLOGY | ASSOCIATION | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Humans | Middle Aged | Biotransformation - genetics | Male | Carboplatin - pharmacokinetics | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Carboplatin - adverse effects | Anemia - genetics | Glutathione Transferase - physiology | Gene Deletion | Hodgkin Disease - mortality | Vincristine - administration & dosage | Neoplasm Proteins - genetics | Glutathione S-Transferase pi - genetics | Dacarbazine - administration & dosage | Genetic Predisposition to Disease | Prednisone - adverse effects | Anemia - chemically induced | Carboplatin - administration & dosage | Etoposide - administration & dosage | Genotype | Bleomycin - administration & dosage | Doxorubicin - pharmacokinetics | Polymorphism, Genetic | Lomustine - pharmacokinetics | Procarbazine - adverse effects | Vincristine - adverse effects | Cyclophosphamide - pharmacokinetics | Lomustine - administration & dosage | Epirubicin - adverse effects | Etoposide - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Hodgkin Disease - genetics | Lomustine - adverse effects | Neoplasm Proteins - physiology | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Bleomycin - pharmacokinetics | Epirubicin - administration & dosage | Glutathione S-Transferase pi - physiology | Hodgkin Disease - enzymology | Vinblastine - pharmacokinetics | Glutathione Transferase - genetics | Vinblastine - adverse effects | Vindesine - adverse effects | Hodgkin Disease - drug therapy | Adult | Dacarbazine - pharmacokinetics | Female | Vindesine - pharmacokinetics | Vincristine - pharmacokinetics | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Treatment Outcome | Bleomycin - adverse effects | Procarbazine - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Prednisone - pharmacokinetics | Vindesine - administration & dosage | Epirubicin - pharmacokinetics | Polymorphism, Single Nucleotide | Doxorubicin - adverse effects | Index Medicus
Journal Article
Hematology Reports (formerly Hematology Reviews), ISSN 2038-8322, 10/2011, Volume 3, Issue 3s, pp. e4 - e4
Since anthracyclines were introduced in the treatment of non-Hodgkin’s lymphoma in the late 1960s, they have been acknowledged as a cornerstone in the... 
non-Hodgkin’s lymphoma, treatment, anthracycline
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 2006, Volume 47, Issue 3, pp. 473 - 479
Journal Article
Blood, ISSN 0006-4971, 11/2008, Volume 112, Issue 11, pp. 3753 - 3753
Abstract Purpose: The aim of the present study was to evaluate incidence, clinical characteristics and survival of non splenic marginal zone lymphomas (NS-MZL)... 
Journal Article
Journal Article
Expert review of hematology, 10/2009, Volume 2, Issue 5, p. 549
Despite significant improvements in treatment modalities over the 10 years, the clinical course of patients with follicular lymphoma (FL) remains... 
Animals | Lymphoma, Follicular - genetics | Prognosis | Lymphoma, Follicular - pathology | Humans | Lymphoma, Follicular - diagnosis | Gene Expression Profiling
Journal Article
Blood, ISSN 0006-4971, 11/2006, Volume 108, Issue 11, pp. 2434 - 2434
Abstract The achievement of a clinical response to the first part of induction chemotherapy has been considered for predicting survival in patients with... 
Journal Article
Phytochemistry, ISSN 0031-9422, 2011, Volume 72, Issue 18, pp. 2317 - 2324
fruit body develops from the ectomycorrhized plants. The occurrence of melanin in the truffle hyphae, spores and fruit body is evident. ► In truffle... 
Fungi | Development | Truffles | Tyrosinase | Melanin | BIOCHEMISTRY & MOLECULAR BIOLOGY